ATE410169T1 - Verwendung eines phenothiazin-derivats zur prävention und/oder behandlung von gerhörverlust - Google Patents

Verwendung eines phenothiazin-derivats zur prävention und/oder behandlung von gerhörverlust

Info

Publication number
ATE410169T1
ATE410169T1 AT05744629T AT05744629T ATE410169T1 AT E410169 T1 ATE410169 T1 AT E410169T1 AT 05744629 T AT05744629 T AT 05744629T AT 05744629 T AT05744629 T AT 05744629T AT E410169 T1 ATE410169 T1 AT E410169T1
Authority
AT
Austria
Prior art keywords
prevent
hearing loss
phenothiazine derivative
treat hearing
treat
Prior art date
Application number
AT05744629T
Other languages
English (en)
Inventor
Bernadette Pignol
Jean-Luc Puel
Serge Auvin
De Lassauniere Pierre Chabrier
Jing Wang
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0403203A external-priority patent/FR2867979B1/fr
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Application granted granted Critical
Publication of ATE410169T1 publication Critical patent/ATE410169T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B21/00—Thiazine dyes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT05744629T 2004-03-29 2005-03-25 Verwendung eines phenothiazin-derivats zur prävention und/oder behandlung von gerhörverlust ATE410169T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0403203A FR2867979B1 (fr) 2004-03-29 2004-03-29 Nouvelle application therapeutique d'un derive de la phenothiazine
FR0406404 2004-06-14

Publications (1)

Publication Number Publication Date
ATE410169T1 true ATE410169T1 (de) 2008-10-15

Family

ID=34968214

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05744629T ATE410169T1 (de) 2004-03-29 2005-03-25 Verwendung eines phenothiazin-derivats zur prävention und/oder behandlung von gerhörverlust

Country Status (14)

Country Link
US (1) US7696197B2 (de)
EP (1) EP1732567B1 (de)
JP (1) JP5066444B2 (de)
AR (1) AR048195A1 (de)
AT (1) ATE410169T1 (de)
CA (1) CA2560988A1 (de)
DE (1) DE602005010222D1 (de)
DK (1) DK1732567T3 (de)
ES (1) ES2315868T3 (de)
HK (1) HK1101545A1 (de)
PL (1) PL1732567T3 (de)
PT (1) PT1732567E (de)
RU (1) RU2377992C2 (de)
WO (1) WO2005092345A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5280850B2 (ja) * 2005-10-21 2013-09-04 イプセン ファルマ ソシエテ パール アクシオン サンプリフィエ アミジン誘導体及びその薬剤としての使用
FR2892415B1 (fr) * 2005-10-21 2007-11-30 Sod Conseils Rech Applic Derives d'amidine et leurs applications a titre de medicament
FR2898274B1 (fr) * 2006-03-07 2008-10-03 Sod Conseils Rech Applic Composition contenant des derives d'amidine ou de carboxamide et des steroides a titre de medicament
US8460639B2 (en) * 2008-12-25 2013-06-11 Canon Kabushiki Kaisha Probe for a hair cell, and labelling method for a hair cell using the probe for a hair cell
GB2467561A (en) * 2009-02-06 2010-08-11 Summit Corp Plc Dual calpain-ROS inhibitors
WO2013176955A1 (en) * 2012-05-21 2013-11-28 The General Hospital Corporation Cardioprotective compounds, their use with chemotherapy, and methods for identifying them
EP2970311A4 (de) 2013-03-14 2016-11-23 Brigham & Womens Hospital Bmp-hemmer und verfahren zur verwendung davon
RU2529700C1 (ru) * 2013-04-12 2014-09-27 Закрытое Акционерное Общество "Клинский институт охраны и условий труда "ОЛС-Комплект" Способ профилактики профессиональной потери слуха
WO2016011019A1 (en) 2014-07-15 2016-01-21 The Brigham And Women's Hospital, Inc. Compositions and methods for inhibiting bmp
US20180161459A1 (en) * 2014-08-29 2018-06-14 Sound Pharmaceuticals Incorporated Methods of Screening for Drugs to Prevent Noise-Induced Hearing Loss
JP6999896B2 (ja) 2017-09-21 2022-01-19 学校法人慶應義塾 音響外傷難聴モデル動物の作製方法及びそれにより作製される音響外傷難聴モデル動物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2389685C (fr) * 1999-11-05 2011-07-12 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R) Nouveaux composes heterocycliques et leur application a titre de medicaments
FR2816509B1 (fr) * 2000-11-15 2004-02-06 Sod Conseils Rech Applic Association d'inhibiteurs de calpaine et de piegeurs des formes reactives de l'oxygene
FR2863268B1 (fr) * 2003-12-09 2006-02-24 Sod Conseils Rech Applic Nouveaux derives du 2-hydroxytetrahydrofuranne et leur application a titre de medicaments

Also Published As

Publication number Publication date
US7696197B2 (en) 2010-04-13
RU2006138035A (ru) 2008-05-10
DE602005010222D1 (de) 2008-11-20
JP5066444B2 (ja) 2012-11-07
US20080275034A1 (en) 2008-11-06
PT1732567E (pt) 2009-01-14
EP1732567A1 (de) 2006-12-20
AR048195A1 (es) 2006-04-05
PL1732567T3 (pl) 2009-04-30
RU2377992C2 (ru) 2010-01-10
EP1732567B1 (de) 2008-10-08
HK1101545A1 (en) 2007-10-18
DK1732567T3 (da) 2009-02-09
JP2007530640A (ja) 2007-11-01
ES2315868T3 (es) 2009-04-01
WO2005092345A1 (fr) 2005-10-06
CA2560988A1 (fr) 2005-10-06

Similar Documents

Publication Publication Date Title
ATE410169T1 (de) Verwendung eines phenothiazin-derivats zur prävention und/oder behandlung von gerhörverlust
ATE513550T1 (de) Verwendung eines ibat-hemmers zur behandlung oder vorbeugung von verstopfung
ATE499105T1 (de) Behandlung oder vorbeugung von haut- oder gewebezuständen bei tieren unter verwendung von boryloxypyridylmethanonen
ATE414556T1 (de) Verwendung von il-18-inhibitoren zur behandlung und/oder prävention von peripheren gefässkrankheiten
ATE489955T1 (de) Verfahren und zusammensetzung zur behandlung von peripheren gefässkrankheiten
ATE448206T1 (de) Benzochinazolinderivate und ihre verwendung bei der behandlung von knochenerkrankungen
ATE414089T1 (de) Verwendung von rapamycin und dessen derivaten zur behandlung von knochenverlust
ATE509615T1 (de) Verfahren und zusammensetzungen zur verhütung und/oder zur behandlung von empfindlicher und/oder trockener haut
DE602005026984D1 (de) Chinolin-derivate zur behandlung von latenter tuberkulose
DE602005023172D1 (de) Hydantoinderivate zur behandlung von entzündlichen erkrankungen
DE602006006354D1 (de) Pinolensäure zur Behandlung von Übergewicht
ATE523594T1 (de) Modifizierung von pflanzenentwicklung und - morphologie
ATE495179T1 (de) Tetrahydropyridothienpyrimidin-verbindungen und verwendung zur behandlung proliferativer erkrankungen
DE50306850D1 (de) Benzodiazepin-substituierte piperdine zur verwendung in der behandlung von cardiovaskulären erkrankungen
DE602007011052D1 (de) Behandlung von mineralschlämmen mit verbesserter pflanzenwachstumsrehabilitation
ATE464895T1 (de) Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von depressionen
ATE509621T1 (de) Verwendung von 2,5-dihydroxybenzolderivaten zur behandlung von arthritis und schmerzen
DE602006017367D1 (de) Amino-oxo-indolyliden-verbindungen zur verwendung in der behandlung von juckender kopfhaut
ATE542804T1 (de) 5-phenyl-pentansäurederivate als matrixmetalloproteinase-inhibitoren zur behandlung von asthma und anderen erkrankungen
ATE395075T1 (de) Verwendung von il-18 inhibitoren zur behandlung und/oder prävention von atherosklerose
DE602005016141D1 (de) S-mirtazapin zur behandlung von hitzewallungen
ATE504297T1 (de) Visnadin zur behandlung von kopfhautjucken
DE602004022035D1 (de) Verwendung von pthalide derivativen zur behandlung
FI20040675A0 (fi) Menetelmä sydämen hypertrofian hoitoon ja estoon
ATE380558T1 (de) Verwendung von il-18 hemmern zur behandlung und/oder prävention von herzkrankheiten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1732567

Country of ref document: EP